Search research articles
Contact Us
Filters
Showing results (81-90 of 126) with videos related to
Page
of 13
Sort By:
BMJ Open
|
February 6, 2024
Protocol of a scoping review of outcome domains in dermatology
Umer Nadir, Areeba Ahmed, Michael D Yi, et al.
JAMA Dermatology
|
April 23, 2020
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis
Aaron M Drucker, Alexandra G Ellis, Michal Bohdanowicz, et al.
Acta Dermato-Venereologica
|
August 20, 2020
Towards More Shared Decision Making in Dermatology: Develop-ment of Evidence-based Decision Cards for Psoriasis and Atopic Eczema Treatments
Francisca M Vermeulen, Gayle E van der Kraaij, Ronald A Tupker, et al.
Expert Opinion on Drug Safety
|
June 12, 2020
Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics
Leanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
JAMA Dermatology
|
December 20, 2013
Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-up
Stef P Menting, Paula P M van Lümig, Anna-Christa Q de Vries, et al.
The Journal of Investigative Dermatology
|
June 1, 2017
The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries
Phyllis I Spuls, Louise A A Gerbens, Christian J Apfelbacher, et al.
JAMA Dermatology
|
July 17, 2024
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update
Aaron M Drucker, Megan Lam, David Prieto-Merino, et al.
The British Journal of Dermatology
|
October 13, 2023
Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis
Aaron M Drucker, Megan Lam, Rawaan Elsawi, et al.
Expert Opinion on Drug Safety
|
August 5, 2021
Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes
Leanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
The Journal of Allergy and Clinical Immunology
|
March 30, 2022
The HOME Core outcome set for clinical trials of atopic dermatitis
Hywel C Williams, Jochen Schmitt, Kim S Thomas, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 126) with videos related to
Sort By:
Page
of 13
BMJ Open
|
February 6, 2024
Protocol of a scoping review of outcome domains in dermatology
Umer Nadir, Areeba Ahmed, Michael D Yi, et al.
JAMA Dermatology
|
April 23, 2020
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis
Aaron M Drucker, Alexandra G Ellis, Michal Bohdanowicz, et al.
Acta Dermato-Venereologica
|
August 20, 2020
Towards More Shared Decision Making in Dermatology: Develop-ment of Evidence-based Decision Cards for Psoriasis and Atopic Eczema Treatments
Francisca M Vermeulen, Gayle E van der Kraaij, Ronald A Tupker, et al.
Expert Opinion on Drug Safety
|
June 12, 2020
Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics
Leanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
JAMA Dermatology
|
December 20, 2013
Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-up
Stef P Menting, Paula P M van Lümig, Anna-Christa Q de Vries, et al.
The Journal of Investigative Dermatology
|
June 1, 2017
The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries
Phyllis I Spuls, Louise A A Gerbens, Christian J Apfelbacher, et al.
JAMA Dermatology
|
July 17, 2024
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update
Aaron M Drucker, Megan Lam, David Prieto-Merino, et al.
The British Journal of Dermatology
|
October 13, 2023
Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis
Aaron M Drucker, Megan Lam, Rawaan Elsawi, et al.
Expert Opinion on Drug Safety
|
August 5, 2021
Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes
Leanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
The Journal of Allergy and Clinical Immunology
|
March 30, 2022
The HOME Core outcome set for clinical trials of atopic dermatitis
Hywel C Williams, Jochen Schmitt, Kim S Thomas, et al.
Page
of 13